Leo Lapuerta in Houston, our medically supervised weight loss program offers tirzepatide injections in a safe, supportive setting
The proven efficacy of semaglutide has made it a first-line therapy for many patients
Genetic Predispositions and Metabolic Context Variation in genes encoding GLP-1 receptors (GLP1R), GIP receptors (GIPR), and metabolic regulators like FTO and MC4R may influence how individuals respond to tirzepatide-based therapy
The SURPASS trials (studying tirzepatide for diabetes) showed approximately 5 to 13 percent weight loss over 40 to 52 weeks, compared to 16 to 22.5 percent in the SURMOUNT obesity trials
Lipid Profile Tirzepatide was associated with dose-dependent favourable effects on lipid profile, including reductions in triglycerides and very-low-density lipoprotein cholesterol (VLDL-C), and increases in high-density lipoprotein cholesterol (HDL-C) in SURPASS-15 [8,9,10,11,12]
Leptin, however, has never been useful in the treatment of obesity, even in individuals who are leptin deficient
